Senolytics prevent mt-DNA-induced inflammation and promote the survival of aged organs following transplantation
Organ transplantation involving aged donors is often confounded by reduced post-transplantation organ survival. By studying both human organs and mouse transplantation models, here the authors show that pretreating the donors with senolytics to reduce mitochondria DNA and pro-inflammatory dendritic...
Guardado en:
Autores principales: | Jasper Iske, Midas Seyda, Timm Heinbokel, Ryoichi Maenosono, Koichiro Minami, Yeqi Nian, Markus Quante, Christine S. Falk, Haruhito Azuma, Friederike Martin, João F. Passos, Claus U. Niemann, Tamara Tchkonia, James L. Kirkland, Abdallah Elkhal, Stefan G. Tullius |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2a2a4da6a7984ebfa0d0c386e1408c60 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of HSP90 inhibitors as a novel class of senolytics
por: Heike Fuhrmann-Stroissnigg, et al.
Publicado: (2017) -
Senolytic Therapy for Cerebral Ischemia-Reperfusion Injury
por: Songhyun Lim, et al.
Publicado: (2021) -
Senolytics: A Novel Strategy for Neuroprotection in ALS?
por: Alexandra Maximova, et al.
Publicado: (2021) -
Identification and characterization of Cardiac Glycosides as senolytic compounds
por: Francisco Triana-Martínez, et al.
Publicado: (2019) -
Evaluating the neuroprotective impact of senolytic drugs on human vision
por: Nevin W. El-Nimri, et al.
Publicado: (2020)